HomeNewsBusinessEarningsPharma, IT, banks best poised post-Q2 earnings, says Kunal Shah of Carnelian Capital

Pharma, IT, banks best poised post-Q2 earnings, says Kunal Shah of Carnelian Capital

Pharma has emerged as the real star this earnings season, but banks are poised to join the rally soon as NIM pressure is behind them. Expect IT earnings to bottom out in the next one to two quarters, he said.

November 21, 2023 / 09:00 IST
Story continues below Advertisement
IT best poised post Q2?
Pharma the star of Q2 earnings season

Kunal Shah of Carnelian Capital shares insights on the current market trends, focusing on key sectors such as information technology (IT), real estate, banking, and non-banking financial companies (NBFCs). Despite a muted second-quarter performance in the IT sector, Shah suggests that valuations, especially in large-cap IT, remain in the comfort zone. In an interview with Moneycontrol, he discusses the promising outlook for real estate stocks, emphasising the importance of playing through ancillaries rather than directly investing in real estate.

Additionally, Shah delves into the impact of the Reserve Bank of India's crackdown on unsecured loans, particularly on NBFCs, highlighting potential challenges for players like Bajaj Finance. Top banking and NBFC stocks, including SBI Card, Bajaj Finance, HDFC Bank, and ICICI Bank, came under selling pressure after the Reserve Bank of India (RBI) tightened norms for personal loans and credit cards to check the unbridled growth in this segment. The central bank has raised credit risk weights on unsecured consumer loans by increasing the capital requirements for such loans, as concerns have been growing over these borrowings. Edited excerpts of the interview:

Story continues below Advertisement

What is driving so much interest in IT stocks despite a muted Q2 show? Following a meeting with seven IT firms, Jefferies has said that the near-term growth outlook remains weak as demand uncertainty persists and revenue leakage could increase in Q3. Do you think valuations have run out of the comfort zone after the recent upmove?

Frankly, I don't feel that IT valuations are no longer in the comfort zone, except for a few stocks in the mid-cap space. Valuations in the mid-cap IT space are in the euphoric zone or have caught up. There's a lot more valuation comfort in the large-cap IT space. Coming to the demand scenario, somewhere we believe that the bottom for the demand scenario is already in place. We only expect improvement hereon.